"Airway smooth muscle area to predict steroid responsiveness in COPD patients receiving triple therapy (HISTORIC): a randomised, placebo-controlled, double-blind, investigator-initiated trial." D. Stolz, E. Papakonstantinou, M. Pascarella, et al. Eur Respir J 2023; 62: 2300218
- PMID: 37827551
- DOI: 10.1183/13993003.50218-2023
"Airway smooth muscle area to predict steroid responsiveness in COPD patients receiving triple therapy (HISTORIC): a randomised, placebo-controlled, double-blind, investigator-initiated trial." D. Stolz, E. Papakonstantinou, M. Pascarella, et al. Eur Respir J 2023; 62: 2300218
Erratum for
-
Airway smooth muscle area to predict steroid responsiveness in COPD patients receiving triple therapy (HISTORIC): a randomised, placebo-controlled, double-blind, investigator-initiated trial.Eur Respir J. 2023 Jul 20;62(1):2300218. doi: 10.1183/13993003.00218-2023. Print 2023 Jul. Eur Respir J. 2023. PMID: 37385657 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources